Tg Therapeutics (TGTX) Receivables - Other (2010 - 2024)
Tg Therapeutics (TGTX) recorded quarterly Receivables - Other of $23.5 million in Q4 2024, up 261.54% quarter-over-quarter from $6.5 million in Q1 2024, and up 298.31% on a YoY basis from $5.9 million in Q1 2024.
Tg Therapeutics (TGTX) Receivables - Other (2010 - 2024) Analysis & Trends
Tg Therapeutics' Receivables - Other history runs 9 years deep, the most recent figure standing at $23.5 million for Q4 2024.
- In Q4 2024, Receivables - Other rose 298.31% year-over-year to $23.5 million; the TTM figure through Dec 2024 stood at $23.5 million (up 298.31% YoY), while the FY2024 annual figure was $23.5 million, up 298.31% from the prior year.
- Receivables - Other was $23.5 million for Q4 2024 at Tg Therapeutics, up from $6.5 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $23.5 million in Q4 2024 to a low of $5.9 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 23.50 Mn |
| Dec 31, 2024 | 23.50 Mn |
| Mar 31, 2024 | 6.50 Mn |
| Mar 31, 2024 | 6.50 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Dec 31, 2023 | 5.90 Mn |
| Sep 30, 2023 | 6.80 Mn |
| Sep 30, 2023 | 6.80 Mn |
| Dec 31, 2018 | 95,000.00 |
| Dec 31, 2018 | 95,000.00 |
| Sep 30, 2018 | 80,000.00 |
| Sep 30, 2018 | 80,000.00 |
| Jun 30, 2018 | 87,000.00 |
| Jun 30, 2018 | 87,000.00 |
| Mar 31, 2018 | 79,000.00 |
| Mar 31, 2018 | 79,000.00 |
| Dec 31, 2017 | 108,000.00 |
| Dec 31, 2017 | 108,000.00 |
| Jun 30, 2017 | 43,290.00 |
| Jun 30, 2017 | 43,290.00 |